Watchlist

Watchlist
AbbVie Inc. (ABBV)
Big Pharma Levers Up As Deal Activity Settles Down
After a red-hot start to 2018 with over $27 billion in deals closed in January alone, biotech sector activity has slowed down, leaving investors hungry for the next big deal. This month has seen a potential boon to biotech activity as three large-cap biotech/pharma companies lined up debt …
BeiGene's zanubrutinib shows encouraging action in early-stage lymphoma study
Preliminary data from a China-based Phase 1 clinical trial evaluating BeiGene's (NASDAQ: BGNE ) BTK inhibitor zanubrutinib in patients with B-cell lymphoma showed a treatment effect. The results were presented at the Annual Meeting of the Chinese Society of Clinical Oncology in Xiamen. …
AbbVie Class Action: Bernstein Liebhard LLP Announces That A Securities Class Action Lawsuit Has Been Filed Against AbbVie Inc. - ABBV
NEW YORK , Sept. 23, 2018 /PRNewswire/ --Bernstein Liebhard LLP, anationally acclaimed investor rights law firm, announces that a securities class action lawsuit has been filed on behalf of those who purchased or acquired the securities of AbbVie Inc. ("AbbVie" or the "…
AbbVie Inc. (ABBV)